The secalosides, novel tumor cell growth inhibitory glycosides from a pollen extract Journal Article


Authors: Jaton, J. C.; Roulin, K.; Rose, K.; Sirotnak, F. M.; Lewenstein, A.; Brunner, G.; Fankhauser, C. P.; Burger, U.
Article Title: The secalosides, novel tumor cell growth inhibitory glycosides from a pollen extract
Abstract: The pollen of rye (Secale cereale) was shown to contain a biologically highly active family of glycosides called the secalosides. Secalosides A and B (1), both of molecular formula C46H51-NO24, were found to be epimeric esters of (2-oxo-3-indolyl)acetic acid (4). They are made up, in addition to this heterocyclic aglycon I (4), of three hexose building blocks and a carbocyclic aglycon II, which is an indan-derived dicarboxylic acid (5). In aqueous solution, secalosides A and B interchanged by epimerization at the chiral center of 4. A further epimeric pair, secalosides C and D (2), contain one additional glucose building block. Secalosides A and B, the racemic aglycon I (4), and 2-oxo-1,2,3,4-tetrahydroquinoline-4-carboxylic acid (3), which results from 4 by hydrolytic rearrangement, exhibited significant antitumor activity against S180 sarcoma in vivo. IC50 values obtained were about 5 μg/mouse for the secalosides and 1 μg/mouse for 3 and 4.
Keywords: unclassified drug; drug activity; nonhuman; animal cell; antineoplastic activity; cancer cell culture; drug structure; animalia; cancer inhibition; structure analysis; drug isolation; glycoside; article; pollen extract; secaloside; secale cereale
Journal Title: Journal of Natural Products
Volume: 60
Issue: 4
ISSN: 0163-3864
Publisher: American Chemical Society  
Date Published: 1997-04-01
Start Page: 356
End Page: 360
Language: English
DOI: 10.1021/np9606557
PUBMED: 9134744
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 17 March 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Francis M Sirotnak
    184 Sirotnak